Dark Light

Follow
- New Adventures with Innovation Toronto
  
  Innovation Toronto has been running since 2007 and as such is getting a little old in terms of its constituent parts. the theme in particular has been a problem mainly because we relied too much on some of the components attached to it and therefore could not move on without extensive work. it is now come to the point where that extensive work is going to produce good results. we are already in the process of updating and upgrading various parts of it and over time will make sure that each and every post has been Revisited and revamped so it presents as best it can.
  
  Testing

Dark Light

Follow
- New Adventures with Innovation Toronto
  
  Innovation Toronto has been running since 2007 and as such is getting a little old in terms of its constituent parts. the theme in particular has been a problem mainly because we relied too much on some of the components attached to it and therefore could not move on without extensive work. it is now come to the point where that extensive work is going to produce good results. we are already in the process of updating and upgrading various parts of it and over time will make sure that each and every post has been Revisited and revamped so it presents as best it can.
  
  Testing

small-molecule drugs

In this illustration, ERX-41 (green stick figure) is bound to the lysosomal acid lipase A protein, a process that leads to cancer-cell death.

A new molecule kills a broad spectrum of hard-to-treat cancers including triple-negative breast cancer

Cutting waste and energy usage significantly in the manufacturing of pharmaceuticals

Reprogramming rapamycin allows the creation of a wide range of amazing new small-molecule drugs